P
Phathom Pharmaceuticals, Inc.
PHAT · NASDAQ · Healthcare · 775M
Closing price
$7.25
+1.68% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-4.0×
Free cash flow yieldFCF yield
-31.5%
Return on equityROE
50.5%
Operating margin
-91.4%
Net debt / EBITDAbalance-sheet strength
-0.5×
Interest coverage
-2.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.